About Aoweisi
Three product lines. One technology platform.
Company Overview
Synthetic biology exosome technology, reimagining health materials
Aoweisi Health was founded in 2023 with synthetic biology exosome technology at its core, focused on biological material R&D and end-to-end manufacturing in three domains: skincare, women's health, and respiratory care. Our mission is to systematically translate cutting-edge synthetic biology into stable, scalable, high-quality biological products — offering full-chain services from formulation development to commercial manufacturing for global brands, medical institutions, and research partners.
Mission
To systematically translate synthetic biology exosome potential into deployable, traceable biological health materials — providing scientific backing for professional health services.
Vision
To become the world's leading synthetic biology exosome application platform — empowering brands and partner institutions to build differentiated, science-driven product competitiveness.
Technology Platform
Synthetic biology exosome platform
Unlike purely nature-derived exosome approaches, Aoweisi applies synthetic biology to engineer exosomes for full control from production consistency to application targeting.
Engineered Exosome Design & Targeted Delivery
Synthetic biology engineering of exosomes for precise tissue targeting, enabling efficient local delivery of active factors to skin, mucosal, and airway target tissues.
Lyophilization & Formulation Consistency
Proprietary lyophilization process stabilizes exosome bioactivity at 98.6% retention under ambient storage, eliminating cold-chain dependency and reducing logistics cost and compliance burden.
End-to-End QC Traceability & Batch Consistency
Full-chain QC traceability from raw materials to finished product, combined with intra- and inter-batch consistency management, delivering a 99.2% factory quality pass rate.
Development Path
From platform to market
Aoweisi has built a clear development path around technology maturation, product line completion, and global OEM/ODM service network establishment.
Certifications & Quality
Patents, process & quality systems
From core formulation patents to batch quality certification, Aoweisi's technical capabilities and quality standards are backed by quantifiable metrics and independent certification — providing credible scientific assurance for partners.
Core Formulation Patents
Covering extraction, exosome engineering, lyophilization stabilization, and targeted delivery
Bioactivity Retention
Core lyophilization metric — full lifecycle bioactivity maintained under ambient storage conditions
Batch Quality Pass Rate
Guaranteed by end-to-end QC traceability from raw material intake to finished product release
Next Step
Explore our research system or start an OEM/ODM partnership conversation
Aoweisi offers a unified public information platform and dedicated partnership channels for brands, research institutions, and channel clients. Whether your next step is understanding the science or opening a manufacturing conversation, we are ready.